- Home
- ZIP vs RNAC Comparison
ZIP vs RNAC Comparison
Compare ZIP & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIP | RNAC |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.2M | 282.9M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZIP | RNAC |
|---|---|---|
| Price | $3.05 | $9.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $3.88 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 591.9K | 423.6K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $448,952,000.00 | $2,797,000.00 |
| Revenue This Year | $1.00 | N/A |
| Revenue Next Year | $5.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $5.60 |
| 52 Week High | $5.61 | $14.56 |
Technical Indicators
Market Signals| Indicator | ZIP | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 64.10 |
| Support Level | $2.89 | $9.13 |
| Resistance Level | $3.08 | $9.97 |
| Average True Range (ATR) | 0.36 | 1.13 |
| MACD | -0.05 | 0.34 |
| Stochastic Oscillator | 13.57 | 80.08 |
Price Performance
Historical ComparisonAbout ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace that connects job seekers and employers through an AI-powered platform. The company provides recruiting solutions that help employers identify and hire qualified candidates while enabling job seekers to discover relevant job opportunities through intelligent matching and recommendation tools.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.